Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

Dana-Farber researchers identified factors predicting the success of donor lymphocyte infusion (DLI) in treating relapsed AML ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics achieved a significant finding in ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

The findings were published in Science Immunology. "Relapse of AML after stem cell transplant is a major challenge," says first author Katie Maurer, MD, Ph.D.. "There are few effective therapies ...

The findings were published in Science Immunology. Relapse of AML after stem cell transplant is a major challenge. There are few effective therapies, and patient outcomes after relapse are poor." ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in ...

This project has not set up a SECURITY.md file yet.